Global and United States Non-Hematological Cancers Market Report & Forecast 2023-2028

Report ID: 1860795 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Non-Hematological Cancers Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Non-Hematological Cancers Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Non-Hematological Cancers Market Size for the Year 2017-2028
        1.2.2 Global Non-Hematological Cancers Market Size for the Year 2017-2028
    1.3 Non-Hematological Cancers Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Non-Hematological Cancers in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Non-Hematological Cancers Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Non-Hematological Cancers Market Dynamics
        1.4.1 Non-Hematological Cancers Industry Trends
        1.4.2 Non-Hematological Cancers Market Drivers
        1.4.3 Non-Hematological Cancers Market Challenges
        1.4.4 Non-Hematological Cancers Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Non-Hematological Cancers by Type
    2.1 Non-Hematological Cancers Market Segment by Type
        2.1.1 Chemotherapy
        2.1.2 Surgery
        2.1.3 Radiation Therapy
        2.1.4 Others
    2.2 Global Non-Hematological Cancers Market Size by Type (2017, 2022 & 2028)
    2.3 Global Non-Hematological Cancers Market Size by Type (2017-2028)
    2.4 United States Non-Hematological Cancers Market Size by Type (2017, 2022 & 2028)
    2.5 United States Non-Hematological Cancers Market Size by Type (2017-2028)
3 Non-Hematological Cancers by Application
    3.1 Non-Hematological Cancers Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Oncology Treatment Centre
        3.1.3 Ambulatory Surgery Centers
        3.1.4 Others
    3.2 Global Non-Hematological Cancers Market Size by Application (2017, 2022 & 2028)
    3.3 Global Non-Hematological Cancers Market Size by Application (2017-2028)
    3.4 United States Non-Hematological Cancers Market Size by Application (2017, 2022 & 2028)
    3.5 United States Non-Hematological Cancers Market Size by Application (2017-2028)
4 Global Non-Hematological Cancers Competitor Landscape by Company
    4.1 Global Non-Hematological Cancers Market Size by Company
        4.1.1 Top Global Non-Hematological Cancers Companies Ranked by Revenue (2021)
        4.1.2 Global Non-Hematological Cancers Revenue by Player (2017-2022)
    4.2 Global Non-Hematological Cancers Concentration Ratio (CR)
        4.2.1 Non-Hematological Cancers Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Hematological Cancers in 2021
        4.2.3 Global Non-Hematological Cancers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Non-Hematological Cancers Headquarters, Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Non-Hematological Cancers Headquarters and Area Served
        4.3.2 Global Non-Hematological Cancers Companies Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Non-Hematological Cancers Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Non-Hematological Cancers Market Size by Company
        4.5.1 Top Non-Hematological Cancers Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Non-Hematological Cancers Revenue by Players (2020, 2021 & 2022)
5 Global Non-Hematological Cancers Market Size by Region
    5.1 Global Non-Hematological Cancers Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Non-Hematological Cancers Market Size by Region (2017-2028)
        5.2.1 Global Non-Hematological Cancers Market Size by Region: 2017-2022
        5.2.2 Global Non-Hematological Cancers Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Non-Hematological Cancers Market Size YoY Growth 2017-2028
        6.1.2 North America Non-Hematological Cancers Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Non-Hematological Cancers Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Non-Hematological Cancers Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Non-Hematological Cancers Market Size YoY Growth 2017-2028
        6.3.2 Europe Non-Hematological Cancers Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Non-Hematological Cancers Market Size YoY Growth 2017-2028
        6.4.2 Latin America Non-Hematological Cancers Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Non-Hematological Cancers Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Non-Hematological Cancers Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Company Details
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Non-Hematological Cancers Introduction
        7.1.4 Novartis Revenue in Non-Hematological Cancers Business (2017-2022)
        7.1.5 Novartis Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Non-Hematological Cancers Introduction
        7.2.4 Pfizer Revenue in Non-Hematological Cancers Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Company Details
        7.3.2 Bristol-Myers Squibb Business Overview
        7.3.3 Bristol-Myers Squibb Non-Hematological Cancers Introduction
        7.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2017-2022)
        7.3.5 Bristol-Myers Squibb Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Company Details
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Non-Hematological Cancers Introduction
        7.4.4 Johnson & Johnson Revenue in Non-Hematological Cancers Business (2017-2022)
        7.4.5 Johnson & Johnson Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Non-Hematological Cancers Introduction
        7.5.4 Roche Revenue in Non-Hematological Cancers Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 Amgen
        7.6.1 Amgen Company Details
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Non-Hematological Cancers Introduction
        7.6.4 Amgen Revenue in Non-Hematological Cancers Business (2017-2022)
        7.6.5 Amgen Recent Development
    7.7 Astellas Pharma
        7.7.1 Astellas Pharma Company Details
        7.7.2 Astellas Pharma Business Overview
        7.7.3 Astellas Pharma Non-Hematological Cancers Introduction
        7.7.4 Astellas Pharma Revenue in Non-Hematological Cancers Business (2017-2022)
        7.7.5 Astellas Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Non-Hematological Cancers Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Non-Hematological Cancers Market Trends
    Table 3. Non-Hematological Cancers Market Drivers
    Table 4. Non-Hematological Cancers Market Challenges
    Table 5. Non-Hematological Cancers Market Restraints
    Table 6. Global Non-Hematological Cancers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Non-Hematological Cancers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Non-Hematological Cancers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Non-Hematological Cancers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Non-Hematological Cancers Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Non-Hematological Cancers Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Non-Hematological Cancers Revenue Share by Player, 2017-2022
    Table 13. Global Non-Hematological Cancers Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-Hematological Cancers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Hematological Cancers as of 2021)
    Table 15. Top Players of Non-Hematological Cancers in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Non-Hematological Cancers Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Non-Hematological Cancers Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Non-Hematological Cancers Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Non-Hematological Cancers Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Non-Hematological Cancers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Non-Hematological Cancers Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Non-Hematological Cancers Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Non-Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Non-Hematological Cancers Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Non-Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Non-Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Non-Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novartis Company Details
    Table 31. Novartis Business Overview
    Table 32. Novartis Non-Hematological Cancers Product
    Table 33. Novartis Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 34. Novartis Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Non-Hematological Cancers Product
    Table 38. Pfizer Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Bristol-Myers Squibb Company Details
    Table 41. Bristol-Myers Squibb Business Overview
    Table 42. Bristol-Myers Squibb Non-Hematological Cancers Product
    Table 43. Bristol-Myers Squibb Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 44. Bristol-Myers Squibb Recent Development
    Table 45. Johnson & Johnson Company Details
    Table 46. Johnson & Johnson Business Overview
    Table 47. Johnson & Johnson Non-Hematological Cancers Product
    Table 48. Johnson & Johnson Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 49. Johnson & Johnson Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Non-Hematological Cancers Product
    Table 53. Roche Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Amgen Company Details
    Table 56. Amgen Business Overview
    Table 57. Amgen Non-Hematological Cancers Product
    Table 58. Amgen Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 59. Amgen Recent Development
    Table 60. Astellas Pharma Company Details
    Table 61. Astellas Pharma Business Overview
    Table 62. Astellas Pharma Non-Hematological Cancers Product
    Table 63. Astellas Pharma Revenue in Non-Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 64. Astellas Pharma Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-Hematological Cancers Product Picture
    Figure 2. Global Non-Hematological Cancers Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Non-Hematological Cancers Market Size 2017-2028 (US$ Million)
    Figure 4. United States Non-Hematological Cancers Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Non-Hematological Cancers Market Size 2017-2028 (US$ Million)
    Figure 6. United States Non-Hematological Cancers Market Share in Global 2017-2028
    Figure 7. Non-Hematological Cancers Report Years Considered
    Figure 8. Product Picture of Chemotherapy
    Figure 9. Product Picture of Surgery
    Figure 10. Product Picture of Radiation Therapy
    Figure 11. Product Picture of Others
    Figure 12. Global Non-Hematological Cancers Market Share by Type in 2022 & 2028
    Figure 13. Global Non-Hematological Cancers Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Non-Hematological Cancers Market Share by Type (2017-2028)
    Figure 15. United States Non-Hematological Cancers Market Share by Type in 2022 & 2028
    Figure 16. United States Non-Hematological Cancers Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Non-Hematological Cancers Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Oncology Treatment Centre
    Figure 20. Product Picture of Ambulatory Surgery Centers
    Figure 21. Product Picture of Others
    Figure 22. Global Non-Hematological Cancers Market Share by Application in 2022 & 2028
    Figure 23. Global Non-Hematological Cancers Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Non-Hematological Cancers Market Share by Application (2017-2028)
    Figure 25. United States Non-Hematological Cancers Market Share by Application in 2022 & 2028
    Figure 26. United States Non-Hematological Cancers Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Non-Hematological Cancers Market Share by Application (2017-2028)
    Figure 28. North America Non-Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Non-Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Non-Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Non-Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Non-Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Non-Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Novartis Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 61. Amgen Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 62. Astellas Pharma Revenue Growth Rate in Non-Hematological Cancers Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
Frequently Asked Questions
Non-Hematological Cancers report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-Hematological Cancers report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-Hematological Cancers report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports